The percentage of TIM-3 positive NK cells was increased in MDS patients and this was true for all NK subpopulations: CD16+CD56- (p = 0.0019), CD16-CD56+ (p = 0.0121), CD16+CD56+ (p = 0.0066) (S3 Table). This evidence concerns the gene HAVCR2 and myelodysplastic syndrome.